Lisapharma
Lisapharma is an Italian pharmaceutical company that develops and manufactures sterile injectable medicines as a CMO/CDMO for multinational pharma clients and as a proprietary product manufacturer holding 70+ marketing authorizations across 37 countries.
- Company typePrivate
- Founded1925
- HeadquartersErba, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lisapharma does
Lisapharma is an Italian pharmaceutical company headquartered in Erba (Como), founded in 1925 and specializing in the production and development of sterile injectable medicines. The company operates a dual business model: as a proprietary product manufacturer holding 70+ Marketing Authorizations across therapeutic categories (NSAIDs, muscle relaxants, aminoglycoside antibacterials, corticosteroids, antidotes, calcium channel blockers, anti-peptic ulcer drugs, and sucralfate-based medical devices including the Skincol line), and as a CMO/CDMO serving Italian and multinational pharmaceutical, veterinary, and medical device companies with 60+ customers in 37 countries.
Core technology centers on aseptic manufacturing capability, including isolators for sterility testing and API manipulation, homogenization systems for injectable suspensions, and disposable bag technology for injectable solutions. The facility maintains an AIFA-authorized department for aseptic sterile powder repartition and a separate restructured department for injectable liquid forms, plus an external warehouse. The company holds FDA approval (2023), EU GMP, Veterinary GMP, ISO 9001:2015, and ISO 13485:2021 certifications, enabling export-led distribution with 80% of business conducted internationally.
R&D activity is grounded in four international patents covering self-assembling nanoparticles for biphosphonate cancer therapy, sprayable sucralfate compositions, respirable insulin microparticles, and inhalation powder formulations. The most significant pipeline asset is Edroma, an exclusively licensed calcium phosphate nanoparticle platform loaded with zoledronic acid targeting glioblastoma, holding both EMA and FDA orphan drug designation. The company pursues R&D via academic partnerships with the University of Parma and University of Naples and relied on European Commission SME Instruments grant funding for development.
Lisapharma firmographics
Firmographics- Name
- Lisapharma
- Legal name
- Laboratorio Italiano Biochimico Farmaceutico Lisapharma Spa
- Website
- https://lisapharma.it
- Company type
- Private
- Founded year
- 1925
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lisapharma is an Italian pharmaceutical company that develops and manufactures sterile injectable medicines as a CMO/CDMO for multinational pharma clients and as a proprietary product manufacturer holding 70+ marketing authorizations across 37 countries.
- Ownership category
- akta.pro rank
Lisapharma industry classification
Industry- Product category
- Sterile Injectable Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
- akta.pro secondary industries
- Sterile Injectable Generics (HLAIABAC), Dermatology Specialty Pharmaceuticals (HLAIACAL), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
Keywords
Where Lisapharma is headquartered
LocationHeadquarters
- HQ city
- Erba
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Lisapharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Contract Manufacturing Services (CMO/CDMO): Provides contract manufacturing services for sterile injectable medicines, non-sterile liquids, semi-solids, and medical devices for Italian and multinational pharmaceutical companies.
- Proprietary Pharmaceutical Products: Markets own branded pharmaceutical products including sterile injectables, tablets, and medical devices under own Marketing Authorizations in Italy and abroad.
- Veterinary Products: Provides GMP certified veterinary pharmaceutical products.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Lisapharma product offering
Product offeringCore offering
Lisapharma is a pharmaceutical manufacturer specializing in sterile injectable medicines (solutions, suspensions, and sterile powders), non-sterile liquids, semi-solid topical forms, and medical devices. It sells its own branded products under 70 Marketing Authorizations in Italy and internationally, and provides contract manufacturing (CMO/CDMO) services to Italian and multinational pharmaceutical, veterinary, and medical device companies. It also develops novel drug delivery systems backed by proprietary patented technology including nanoparticle formulations.
Product overview
Lisapharma is a pharmaceutical company specializing in the production of sterile injectable medicines. The company operates as both a proprietary product manufacturer with Marketing Authorizations in Italy and abroad, and as a contract manufacturer (CMO/CDMO) for Italian and multinational pharmaceutical companies. The product portfolio includes: Drugs (Acurmil, Arfen, Calco, Jointral, Likacin, Likacin gel, Lisamethyle, Lisathyone, Nipin, Sucrate gel) covering therapeutic areas including muscle relaxants, NSAIDs, calcium-homeostatics, aminoglycoside antibacterials, corticosteroids, antidotes, calcium channel blockers, and anti-peptic ulcer medications; and Medical Devices (Skincol gel, Skincol spray) for wound treatment. The company also develops injectable solutions, non-sterile liquids, semi-solid topical products (creams, gels, ointments), and holds 4 international patents for drug delivery systems including nanoparticle technology for cancer treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- Arfen NSAID (non-steroidal anti-inflammatory drug) containing Ibuprofen lysine, available in tablet and intramuscular injectable solution forms, used for pain and inflammation management.
- Acurmil Peripheral-action muscle relaxant containing Atracurium Besilate, presented as injectable solution for IV use.
- Calco Calcium-homeostatic agent containing Calcitonin, presented as injectable solution for intramuscular, intravenous, and subcutaneous use.
- Jointral NSAID topical gel containing Ibuprofen lysine for treatment of joint pain and inflammation.
- Likacin Aminoglycoside antibacterial drug containing Amikacin sulphate, presented as injectable solution for intramuscular and intravenous use.
- Likacin gel Topical antibiotic gel containing Amikacin sulphate 5%, used for dermatological treatment of skin infections.
- Lisamethyle Systemic corticosteroid containing Methylprednisolone sodium succinate, presented as powder and solvent for injectable solution for intramuscular and intravenous use.
- Lisathyone Antidote containing Glutathione sodium, presented as powder and solvent for injectable solution for intramuscular and intravenous use.
- Nipin Calcium channel blocker containing Nifedipine, presented as modified-release film-coated tablets for cardiovascular treatment.
- Skincol gel Medical device for treatment of injuries containing Sucralfate humid gel, presented as topical gel in a 30g tube at 25% concentration.
- Skincol spray Medical device spray for treatment of injuries containing Sucralfate gel, presented as topical spray in a 20ml bottle.
- Sucrate gel Drug for treatment of peptic ulcer and gastroesophageal reflux disease containing Sucralfate, presented as oral gel in stick packs.
- Edroma (glioblastoma program) Pharmaceutical product based on a nanotechnology platform: dispersion of calcium phosphate nanoparticles loaded with zoledronic acid for treatment of malignant high-grade gliomas (glioblastoma). In-licensed nanoparticle platform technology (WO2012042024A1, EP2621539 A1, US9226897 B2).
- Contract manufacturing (CMO/CDMO) services Full-service contract manufacturing for Italian and multinational pharmaceutical, veterinary, and medical device companies, covering sterile injectables (solutions, suspensions, sterile powders), non-sterile liquids, semi-solids, and medical devices under EU GMP, Veterinary GMP, FDA, and ISO 13485 certifications.
Quantifiable outcome
- Successfully passed FDA PAI and GMP inspections in 2023
- +2 more outcomes
Companies that use Lisapharma
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Lisapharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Lisapharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Treebu S.r.l. S.B.minorPartnership for creation of Paulownia forest to contribute to climate change fight and environmental sustainability. Lisapharma created a forest of 100 Paulownia plants through this partnership, removing 10 tons of CO2 from the atmosphere.
- NovartiscoreFirst contract manufacturing customer for injectable products since 1993. Represents the foundation of Lisapharma's contract manufacturing business following Italian legislation changes.
- University of ParmaminorAcademic partnership for professional exchanges and collaboration in pharmaceutical research and development. Part of university network cooperation for drug delivery systems development.
- University of NaplesminorAcademic partnership for professional exchanges and collaboration in pharmaceutical research and development. Part of university network cooperation for drug delivery systems development.
Scale indicators7 records
Recent moves11 records
Expansion highlights5 records
Lisapharma competitors and assessment
Company assessmentDirect peers
- ACS Dobfar: Italian pharmaceutical manufacturer and CDMO producing sterile injectable cephalosporins and other injectable antibiotics, with European manufacturing sites; a domestic Italian peer competing for similar sterile injectable contract manufacturing work.
- Aenova Group: German-headquartered CDMO with capabilities in sterile injectables, solids, and semi-solids for pharmaceutical companies across Europe; comparable on contract injectable manufacturing scale and customer type.
- Hovione: Portuguese CDMO with global sterile injectable and inhaled drug product manufacturing; comparable as a European-headquartered CDMO offering injectable contract services to large pharma.
- Cerbios-Pharma: Swiss CDMO specializing in sterile injectable manufacturing including oncology products; similar niche/mid-sized European focus on sterile injectables for multinational pharmaceutical partners.
- BSP Pharmaceuticals: Italian CDMO located close to Lisapharma (Lazio region) specializing in sterile injectable manufacturing for oncology and other injectable products; competes with Lisapharma for European sterile injectable contract volumes.
- Eurofins CDMO (formerly Amatsigroup): European CDMO providing sterile injectable and lyophilized drug product manufacturing services; comparable as a mid-sized European sterile CDMO serving biotech and specialty pharma customers.
- CordenPharma: European CDMO with a leading sterile injectable (injectables) platform serving multinational pharma with aseptic fill-finish and APIs; the closest functional comparable to Lisapharma's CMO/CDMO sterile injectable business.
- Haupt Pharma: European contract manufacturer with sterile injectable and solid dose capabilities serving multinational pharma; directly comparable on contract manufacturing of sterile injectable medicines in the EU.
- Fareva: French-headquartered contract manufacturer offering sterile injectable, liquid, and semi-solid manufacturing for pharmaceutical and cosmetic customers; directly comparable on CMO/CDMO scope and European footprint.
Broad incumbents
- Catalent: Large global CDMO with a major sterile fill-finish and injectable drug product franchise; not niche-comparable but a leading broad incumbent competing for the same multinational sterile injectable CMOs that Lisapharma serves.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lisapharma social profiles
Digital presenceLisapharma compliance and trust
Trust signalCompliance5 records
Lisapharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lisapharma leadership team
Management profileNumber of profiles
Profiles8 records
Lisapharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lisapharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lisapharma
What does Lisapharma do?
Lisapharma is a pharmaceutical manufacturer specializing in sterile injectable medicines (solutions, suspensions, and sterile powders), non-sterile liquids, semi-solid topical forms, and medical devices. It sells its own branded products under 70 Marketing Authorizations in Italy and internationally, and provides contract manufacturing (CMO/CDMO) services to Italian and multinational pharmaceutical, veterinary, and medical device companies. It also develops novel drug delivery systems backed by proprietary patented technology including nanoparticle formulations.
Is Lisapharma a public or private company?
Lisapharma is a private company. It is classified as management employee owned and is currently operating.
When was Lisapharma founded?
Lisapharma was founded in 1925. It employs 11 to 50 people.
Where is Lisapharma based?
Lisapharma is headquartered in Erba, Italy, in the Europe region.
How does Lisapharma make money?
Three revenue lines are on record. Contract Manufacturing Services (CMO/CDMO) is the primary driver. The others are proprietary Pharmaceutical Products and veterinary Products.
Who are Lisapharma's main competitors?
Direct peers on record are ACS Dobfar, Aenova Group, Hovione, Cerbios-Pharma, BSP Pharmaceuticals, Eurofins CDMO (formerly Amatsigroup), CordenPharma, Haupt Pharma and Fareva. Catalent is listed as a broad incumbent.
Does Lisapharma have an API?
No public API is recorded for Lisapharma.
What industry is Lisapharma in?
Lisapharma's product category is Sterile Injectable Pharmaceuticals. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAIABAC, Sterile Injectable Generics. Its NAICS code is 325412 and its SIC code is 2834.